Di(Hydroxyethyl)Ether

Di(Hydroxyethyl)Ether

SCHEMBL4421030

CCCCC(CCC)OC(CCC)CCCC.OCCOCCO

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.56
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
THRB P10828 1/20 0.50
HTT P42858 1/20 0.50
MAPT P10636 1/20 0.50
MAPK1 P28482 2/20 0.40
ALDH1A1 P00352 5/20 0.39
USP2 O75604 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 2/20 0.35
CYP3A4 P08684 1/20 0.35
CASP1 P29466 1/20 0.35
SLCO1B3 Q9NPD5 1/20 0.35
SLCO1B1 Q9Y6L6 1/20 0.35
CTSK P43235 1/20 0.33
ACHE P22303 1/20 0.32
PRKCA P17252 1/20 0.31
PRKCD Q05655 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Triethylene Glycol SCHEMBL25303573 0.98 TSHR (0.54) TSHRMEN1KMT2ATHRBHTT
Triethylene Glycol SCHEMBL25260216 0.92 MEN1 (0.57) TSHRMEN1KMT2ATHRBHTT
Di(Hydroxyethyl)Ether SCHEMBL5141986 0.92 TSHR (0.56) TSHRMEN1KMT2ATHRBHTT
Di(Hydroxyethyl)Ether SCHEMBL4425237 0.92 TSHR (0.52) TSHRMEN1KMT2ATHRBHTT
Triethylene Glycol SCHEMBL25303227 0.91 MEN1 (0.60) TSHRMEN1KMT2ATHRBHTT
Triethylene Glycol SCHEMBL25307288 0.91 MEN1 (0.60) TSHRMEN1KMT2ATHRBHTT
Triethylene Glycol SCHEMBL5146673 0.90 MEN1 (0.59) TSHRMEN1KMT2ATHRBHTT
Di(Hydroxyethyl)Ether SCHEMBL5142109 0.90 MEN1 (0.59) TSHRMEN1KMT2ATHRBHTT
Tetraethylene Glycol SCHEMBL5143949 0.90 MEN1 (0.59) TSHRMEN1KMT2ATHRBHTT
SCHEMBL491059 0.89 MEN1 (0.62) TSHRMEN1KMT2ATHRBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12633572-B2 Electrolytic solution and electrochemical device MURATA MANUFACTURING CO., LTD. (JP) 2026-05-19 US disclosed
US-12095081-B2 Electrolytic solution and electrochemical device MURATA MANUFACTURING CO., LTD. (JP) 2024-09-17 US disclosed
US-20240014378-A1 POSITIVE ELECTRODE AND ELECTROCHEMICAL DEVICE MURATA MANUFACTURING CO., LTD. (JP) 2024-01-11 US disclosed
US-20230231197-A1 ELECTROLYTIC SOLUTION AND ELECTROCHEMICAL DEVICE MURATA MANUFACTURING CO., LTD. (JP) 2023-07-20 US disclosed
WO-2022074999-A1 SECONDARY BATTERY 株式会社村田製作所 2022-04-14 WO disclosed
WO-2022059461-A1 ELECTROLYTE, AND ELECTROCHEMICAL DEVICE 株式会社村田製作所 2022-03-24 WO disclosed
WO-2022054813-A1 ELECTROCHEMICAL DEVICE 株式会社村田製作所 2022-03-17 WO disclosed
CN-108929808-B Cleaning agent composition for lead-free solder flux and method for cleaning lead-free solder flux 荒川化学工业株式会社 2020-11-27 CN disclosed
CN-105814162-B Solvent compositions are used in electric device manufacture 株式会社大赛璐 2019-03-29 CN disclosed
CN-108929808-A The cleaning method of lead-free solder solder flux cleansing composition, lead-free solder solder flux 荒川化学工业株式会社 2018-12-04 CN disclosed
CN-105814162-A Solvent composition for electric device production 株式会社大赛璐 2016-07-27 CN disclosed
US-20090042762-A1 CLEANER COMPOSITION FOR REMOVAL OF LEAD-FREE SOLDERING FLUX, RINSING AGENT FOR REMOVAL OF LEAD-FREE SOLDERING FLUX, AND METHOD FOR REMOVAL OF LEAD-FREE SOLDERING FLUX ARAKAWA CHEMICAL INDUSTRIES, LTD. (JP) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12633572-B2 Electrolytic solution and electrochemical device KCNN1, HCN4, KCNN2 TSHR 312/4885MEN1 801/4885KMT2A 916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.